Markets watch earnings as Medicare Advantage rate proposal hits insurers; chip stocks lift futures

U.S. stock index futures were mixed Tuesday as investors navigated a crowded earnings calendar and a policy signal that rattled parts of the health-insurance sector. In premarket trading, the tech-heavy indexes found support from strength in chip-related shares, while the Dow was weighed down by declines among health insurers and managed-care companies facing new uncertainty around Medicare Advantage reimbursement.

The pressure on insurers followed the Centers for Medicare & Medicaid Services’ release of its advance notice for 2027 Medicare Advantage and Part D payment policies. The proposal projected a net average year-over-year payment increase of 0.09% for 2027 if finalized—far below what many market participants expected based on cost trends and prior rate cycles. Even with adjustments that consider risk score trend, the headline number set the tone for investor caution.

At the same time, corporate results and guidance were steering individual names. Traders focused on quarterly updates from major industrial and consumer-facing companies, looking for clarity on demand and margins after a volatile end to 2025. In the background, investors also kept an eye on the Federal Reserve’s next policy decision, with rate expectations influencing the appetite for growth stocks.

Tech and AI infrastructure spending remained a counterweight to defensive-sector jitters, with the market continuing to reward companies tied to data center buildouts, advanced memory, and semiconductor supply chains. That divergence—AI optimism versus health-policy uncertainty—helped explain why the Nasdaq held up better than blue-chip benchmarks early in the day.

Overall, the session setup underscored a common 2026 theme: policy headlines can move entire sectors quickly, and investors are increasingly treating reimbursement, investigations, and regulatory processes as core inputs in valuation—not just background noise.